应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRSN Mersana Therapeutics Inc.
盘后交易 02-24 18:22:27 EST
0.5566
+0.0234
+4.39%
盘后
0.5599
+0.0033
+0.59%
18:21 EST
最高
0.5656
最低
0.5100
成交量
559.87万
今开
0.5568
昨收
0.5332
日振幅
10.43%
总市值
6,876万
流通市值
4,388万
总股本
1.24亿
成交额
305.23万
换手率
7.10%
流通股本
7,883万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Mersana Therapeutics, Inc.盘中异动 大幅拉升5.03%报0.560美元
市场透视 · 17:44
Mersana Therapeutics, Inc.盘中异动 大幅拉升5.03%报0.560美元
Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.45%
市场透视 · 02-18
Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.45%
Mersana Therapeutics, Inc.盘中异动 急速拉升5.02%
市场透视 · 02-14
Mersana Therapeutics, Inc.盘中异动 急速拉升5.02%
Mersana Therapeutics, Inc.盘中异动 股价大跌5.01%报0.613美元
市场透视 · 02-13
Mersana Therapeutics, Inc.盘中异动 股价大跌5.01%报0.613美元
Mersana Therapeutics, Inc.盘中异动 快速下跌5.33%报0.710美元
市场透视 · 02-10
Mersana Therapeutics, Inc.盘中异动 快速下跌5.33%报0.710美元
Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.00%报0.718美元
市场透视 · 02-07
Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.00%报0.718美元
Mersana Therapeutics, Inc.盘中异动 股价大涨5.37%报0.638美元
市场透视 · 02-05
Mersana Therapeutics, Inc.盘中异动 股价大涨5.37%报0.638美元
Mersana Therapeutics, Inc.盘中异动 股价大涨5.31%报0.595美元
市场透视 · 02-04
Mersana Therapeutics, Inc.盘中异动 股价大涨5.31%报0.595美元
Mersana Therapeutics, Inc.盘中异动 早盘快速下挫5.06%
市场透视 · 02-03
Mersana Therapeutics, Inc.盘中异动 早盘快速下挫5.06%
Mersana Therapeutics, Inc.盘中异动 早盘股价大跌5.47%
市场透视 · 01-31
Mersana Therapeutics, Inc.盘中异动 早盘股价大跌5.47%
Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.617美元
市场透视 · 01-30
Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.617美元
Mersana Therapeutics, Inc.盘中异动 早盘急速跳水5.71%
市场透视 · 01-29
Mersana Therapeutics, Inc.盘中异动 早盘急速跳水5.71%
Mersana Therapeutics, Inc.盘中异动 早盘股价大跌6.05%报0.567美元
市场透视 · 01-28
Mersana Therapeutics, Inc.盘中异动 早盘股价大跌6.05%报0.567美元
Mersana Therapeutics, Inc.盘中异动 股价大跌5.16%
市场透视 · 01-27
Mersana Therapeutics, Inc.盘中异动 股价大跌5.16%
Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报0.550美元
市场透视 · 01-24
Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报0.550美元
Mersana Therapeutics, Inc.盘中异动 股价大跌5.04%报0.522美元
市场透视 · 01-22
Mersana Therapeutics, Inc.盘中异动 股价大跌5.04%报0.522美元
Mersana Therapeutics, Inc.盘中异动 早盘急速下跌5.03%
市场透视 · 01-21
Mersana Therapeutics, Inc.盘中异动 早盘急速下跌5.03%
Mersana Therapeutics, Inc.盘中异动 急速跳水5.03%
市场透视 · 01-17
Mersana Therapeutics, Inc.盘中异动 急速跳水5.03%
Mersana Therapeutics, Inc.盘中异动 早盘快速跳水5.14%
市场透视 · 01-16
Mersana Therapeutics, Inc.盘中异动 早盘快速跳水5.14%
Mersana Therapeutics, Inc.盘中异动 大幅下挫5.05%
市场透视 · 01-15
Mersana Therapeutics, Inc.盘中异动 大幅下挫5.05%
加载更多
公司概况
公司名称:
Mersana Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mersana Therapeutics, Inc.于2002年2月以名称Nanopharma Corp.在特拉华州注册成立。2005年11月,他们更名为Mersana Therapeutics,Inc.。2012年,公司资本重组,并专注于ADC。该公司是一家临床阶段生物制药公司,专注于开发抗体药物共轭物(ADC),为严重未满足需求的癌症患者提供临床意义上的益处。他们利用在ADC领域20年的行业学习开发专有技术,使他们能够相对于现有的ADC治疗设计ADC来提高功效,安全性和耐受性。此外,他们还与武田制药有限公司(武田)建立了战略合作关系,在美国和加拿大境外获得了XMT-1522的权利。他们还与武田和默克KGaA建立了战略研究与开发合作伙伴关系,以便根据其合作伙伴基于其Dolaflexin平台选择的有限数量的目标,开发和商业化其他ADC产品候选人。
发行价格:
--
{"stockData":{"symbol":"MRSN","market":"US","secType":"STK","nameCN":"Mersana Therapeutics Inc.","latestPrice":0.5566,"timestamp":1740430800000,"preClose":0.5332,"halted":0,"volume":5598747,"hourTrading":{"tag":"盘后","latestPrice":0.5599,"preClose":0.5566,"latestTime":"18:21 EST","volume":51009,"amount":28513.6586343,"timestamp":1740439316844},"delay":0,"floatShares":78833761,"shares":123532909,"eps":-0.612564,"marketStatus":"盘后交易","change":0.0234,"latestTime":"02-24 18:22:27 EST","open":0.5568,"high":0.5656,"low":0.51,"amount":3052331.6079564,"amplitude":0.104276,"askPrice":0.572,"askSize":100,"bidPrice":0.5403,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-0.612564,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1740445200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1498622400000,"exchange":"NASDAQ","adjPreClose":0.5332,"preHourTrading":{"tag":"盘前","latestPrice":0.55,"preClose":0.5332,"latestTime":"09:24 EST","volume":28863,"amount":16636.27991688,"timestamp":1740407084367},"postHourTrading":{"tag":"盘后","latestPrice":0.5599,"preClose":0.5566,"latestTime":"18:21 EST","volume":51009,"amount":28513.6586343,"timestamp":1740439316844},"volumeRatio":1.181838,"impliedVol":2.1771,"impliedVolPercentile":0.928},"requestUrl":"/m/hq/s/MRSN","defaultTab":"news","newsList":[{"id":"2514771718","title":"Mersana Therapeutics, Inc.盘中异动 大幅拉升5.03%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514771718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514771718?lang=zh_cn&edition=full","pubTime":"2025-02-25 01:44","pubTimestamp":1740419070,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日01时44分,Mersana Therapeutics, Inc.股票出现波动,股价大幅拉升5.03%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022501443098911e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022501443098911e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","LENZ","MRSN"],"gpt_icon":0},{"id":"2512165164","title":"Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165164?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分,Mersana Therapeutics, Inc.股票出现异动,股价快速上涨5.45%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223146a24aac8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223146a24aac8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LENZ","BK4139","MRSN"],"gpt_icon":0},{"id":"2511962066","title":"Mersana Therapeutics, Inc.盘中异动 急速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511962066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511962066?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:46","pubTimestamp":1739544416,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时46分,Mersana Therapeutics, Inc.股票出现波动,股价大幅拉升5.02%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224657a24604bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224657a24604bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRSN","BK4563","LENZ"],"gpt_icon":0},{"id":"2511052180","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.01%报0.613美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511052180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511052180?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:16","pubTimestamp":1739459793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时16分,Mersana Therapeutics, Inc.股票出现波动,股价大幅跳水5.01%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323163498843551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323163498843551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LENZ","MRSN"],"gpt_icon":0},{"id":"2510070893","title":"Mersana Therapeutics, Inc.盘中异动 快速下跌5.33%报0.710美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510070893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510070893?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:54","pubTimestamp":1739210088,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时54分,Mersana Therapeutics, Inc.股票出现异动,股价大幅下挫5.33%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211015449961e26e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211015449961e26e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRSN","BK4563","BK4139"],"gpt_icon":0},{"id":"2509074425","title":"Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.00%报0.718美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509074425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509074425?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:42","pubTimestamp":1738939349,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时42分,Mersana Therapeutics, Inc.股票出现异动,股价快速上涨5.00%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224229987dafaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224229987dafaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","LENZ","MRSN"],"gpt_icon":0},{"id":"2509282649","title":"Mersana Therapeutics, Inc.盘中异动 股价大涨5.37%报0.638美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509282649?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:38","pubTimestamp":1738766338,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时38分,Mersana Therapeutics, Inc.股票出现波动,股价急速拉升5.37%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522385896190a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522385896190a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LENZ","MRSN"],"gpt_icon":0},{"id":"2509466066","title":"Mersana Therapeutics, Inc.盘中异动 股价大涨5.31%报0.595美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509466066?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:08","pubTimestamp":1738685329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时08分,Mersana Therapeutics, Inc.股票出现波动,股价急速拉升5.31%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.12%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000849a2393b80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000849a2393b80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4563","MRSN"],"gpt_icon":0},{"id":"2508147878","title":"Mersana Therapeutics, Inc.盘中异动 早盘快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508147878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508147878?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:46","pubTimestamp":1738594017,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分,Mersana Therapeutics, Inc.股票出现波动,股价大幅跳水5.06%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224657987971db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224657987971db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","MRSN","LENZ"],"gpt_icon":0},{"id":"2507969545","title":"Mersana Therapeutics, Inc.盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507969545?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:01","pubTimestamp":1738335709,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时01分,Mersana Therapeutics, Inc.股票出现波动,股价大幅下挫5.47%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.39%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131230149abbe4126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131230149abbe4126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4563","BK4139","MRSN"],"gpt_icon":0},{"id":"2507789746","title":"Mersana Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.617美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507789746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507789746?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:06","pubTimestamp":1738253176,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时06分,Mersana Therapeutics, Inc.股票出现异动,股价快速上涨5.08%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131000616a23465b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131000616a23465b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRSN","BK4139","BK4563"],"gpt_icon":0},{"id":"2507631961","title":"Mersana Therapeutics, Inc.盘中异动 早盘急速跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507631961?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:41","pubTimestamp":1738161674,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时41分,Mersana Therapeutics, Inc.股票出现异动,股价急速下跌5.71%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224114a233690a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224114a233690a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRSN","BK4563","LENZ"],"gpt_icon":0},{"id":"2506520514","title":"Mersana Therapeutics, Inc.盘中异动 早盘股价大跌6.05%报0.567美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506520514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506520514?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:40","pubTimestamp":1738075252,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时40分,Mersana Therapeutics, Inc.股票出现波动,股价急速下挫6.05%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282240539612f586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282240539612f586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LENZ","MRSN"],"gpt_icon":0},{"id":"2506530351","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506530351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506530351?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:34","pubTimestamp":1737988440,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时34分,Mersana Therapeutics, Inc.股票出现异动,股价大幅跳水5.16%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223400abba6023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223400abba6023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRSN","BK4563"],"gpt_icon":0},{"id":"2505660548","title":"Mersana Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505660548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505660548?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:42","pubTimestamp":1737729732,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时42分,Mersana Therapeutics, Inc.股票出现波动,股价快速拉升5.65%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242242129872041c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242242129872041c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LENZ","BK4139","MRSN"],"gpt_icon":0},{"id":"2505758567","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.04%报0.522美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505758567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505758567?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:01","pubTimestamp":1737565266,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时01分,Mersana Therapeutics, Inc.股票出现异动,股价大幅跳水5.04%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010106960d178c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010106960d178c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRSN","BK4563"],"gpt_icon":0},{"id":"2505271605","title":"Mersana Therapeutics, Inc.盘中异动 早盘急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271605?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:35","pubTimestamp":1737470137,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时35分,Mersana Therapeutics, Inc.股票出现异动,股价大幅跳水5.03%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223538abb347dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223538abb347dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRSN","BK4139","BK4563","LENZ"],"gpt_icon":0},{"id":"2504195865","title":"Mersana Therapeutics, Inc.盘中异动 急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504195865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504195865?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:02","pubTimestamp":1737129736,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日00时02分,Mersana Therapeutics, Inc.股票出现波动,股价急速下跌5.03%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180002169607ad96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180002169607ad96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LENZ","MRSN"],"gpt_icon":0},{"id":"2503913985","title":"Mersana Therapeutics, Inc.盘中异动 早盘快速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503913985?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:40","pubTimestamp":1737038403,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时40分,Mersana Therapeutics, Inc.股票出现波动,股价快速下跌5.14%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224003a2246193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224003a2246193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRSN","LENZ","BK4563"],"gpt_icon":0},{"id":"2503640606","title":"Mersana Therapeutics, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640606?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951633,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分,Mersana Therapeutics, Inc.股票出现异动,股价快速下挫5.05%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152233539604b49d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152233539604b49d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","MRSN","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mersana.com","stockEarnings":[{"period":"1week","weight":-0.0838},{"period":"1month","weight":0.0108},{"period":"3month","weight":-0.7386},{"period":"6month","weight":-0.6582},{"period":"1year","weight":-0.8589},{"period":"ytd","weight":-0.6271}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.1821},{"period":"ytd","weight":0.0236}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mersana Therapeutics, Inc.于2002年2月以名称Nanopharma Corp.在特拉华州注册成立。2005年11月,他们更名为Mersana Therapeutics,Inc.。2012年,公司资本重组,并专注于ADC。该公司是一家临床阶段生物制药公司,专注于开发抗体药物共轭物(ADC),为严重未满足需求的癌症患者提供临床意义上的益处。他们利用在ADC领域20年的行业学习开发专有技术,使他们能够相对于现有的ADC治疗设计ADC来提高功效,安全性和耐受性。此外,他们还与武田制药有限公司(武田)建立了战略合作关系,在美国和加拿大境外获得了XMT-1522的权利。他们还与武田和默克KGaA建立了战略研究与开发合作伙伴关系,以便根据其合作伙伴基于其Dolaflexin平台选择的有限数量的目标,开发和商业化其他ADC产品候选人。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.054779},{"month":2,"riseRate":0.5,"avgChangeRate":0.136636},{"month":3,"riseRate":0,"avgChangeRate":-0.165787},{"month":4,"riseRate":0.428571,"avgChangeRate":0.027646},{"month":5,"riseRate":0.428571,"avgChangeRate":0.275375},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.078008},{"month":7,"riseRate":0.25,"avgChangeRate":-0.160523},{"month":8,"riseRate":0.5,"avgChangeRate":0.058223},{"month":9,"riseRate":0.25,"avgChangeRate":-0.095374},{"month":10,"riseRate":0.25,"avgChangeRate":-0.038972},{"month":11,"riseRate":0.625,"avgChangeRate":0.219913},{"month":12,"riseRate":0.375,"avgChangeRate":0.000399}],"exchange":"NASDAQ","name":"Mersana Therapeutics Inc.","nameEN":"Mersana Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.2","shortVersion":"4.31.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mersana Therapeutics Inc.(MRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mersana Therapeutics Inc.(MRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mersana Therapeutics Inc.,MRSN,Mersana Therapeutics Inc.股票,Mersana Therapeutics Inc.股票老虎,Mersana Therapeutics Inc.股票老虎国际,Mersana Therapeutics Inc.行情,Mersana Therapeutics Inc.股票行情,Mersana Therapeutics Inc.股价,Mersana Therapeutics Inc.股市,Mersana Therapeutics Inc.股票价格,Mersana Therapeutics Inc.股票交易,Mersana Therapeutics Inc.股票购买,Mersana Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mersana Therapeutics Inc.(MRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mersana Therapeutics Inc.(MRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}